anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Sequoia Pitch

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 43,093
Current window 25,501-25,530
Pages 1,437
Rows per page 30
Arc: Sequoia Pitchclear collectionreset all
18 30 60

Arc

25,501-25,530 of 43,093

filter-aware
07
The slide uses a binary status table (checkmarks and crosses) to indicate product maturity across two categories.Lion Electric | Results Presentation Deck | 21 slides · Lion Electric
Conference presentation Investor relations Beat · Product1 hit
08
Lion Electric | Results Presentation Deck | 21 slidesLion Electric | Results Presentation Deck | 21 slides · Lion Electric
Conference presentation Investor relations Beat · Product1 hit
14
Includes a disclaimer about non-IFRS measures at the bottom.Lion Electric | Results Presentation Deck | 21 slides · Lion Electric
Conference presentation Investor relations Beat · Financials1 hit
15
Includes footnotes regarding FX rates and borrowing base calculations.Lion Electric | Results Presentation Deck | 21 slides · Lion Electric
Conference presentation Investor relations Beat · Financials1 hit
08
Includes a breakdown of revenue by segment and financial performance charts.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Problem1 hit
09
The slide uses a two-column layout: a table for strategic pillars and a list of achievements.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Problem1 hit
13
Includes a table of revenue growth drivers and a stacked bar chart showing revenue mix.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
14
The chart uses a standard waterfall format to bridge beginning cash to ending cash.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
15
Includes YTD 2023 full year outlook projections.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
16
The slide uses a combination of a dual-axis bar/line chart for leverage and a stacked bar chart for liquidity capacity.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
17
The slide provides a comprehensive snapshot of the company's financial health and debt obligations.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
18
The slide includes a detailed disclaimer regarding the assumptions and non-GAAP measures used in the outlook.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
19
The chart uses a standard waterfall bridge format to explain the variance in EPS guidance.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
20
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
21
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
22
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
23
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Solution1 hit
24
Slide 24 of a corporate presentation.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
26
Includes a map of Europe with color-coded regions and location markers.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Market Size1 hit
27
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Market Size1 hit
29
Includes a map of locations, a table of operational metrics, a list of competitors, and a stacked bar chart of revenue.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Competition1 hit
30
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Competition1 hit
05
The slide uses a Gantt-style layout to represent drug development stages.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
MAIA Biotechnology | Investor Presentation Deck | 39 slidesMAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Solution1 hit
10
The slide illustrates the interaction between THIO (telomere targeting) and standard checkpoint inhibitor therapies.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Solution1 hit
11
This slide serves as a validation/traction point by highlighting a partnership with a major pharmaceutical company.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
12
The chart shows tumor volume over time, highlighting the efficacy of the THIO + Atezo combination compared to controls.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
13
The slide outlines a multi-part clinical trial process (Part A, Part B, and Expansion) for NSCLC 2L patients.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
14
The table compares Cyramza+Docetaxel, Docetaxel alone, and THIO+Libtayo across efficacy, safety, and administration metrics.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
15
The slide compares the safety profile of THIO against standard of care (SOC) chemotherapy.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit